InvestorsHub Logo
Followers 10
Posts 529
Boards Moderated 0
Alias Born 12/15/2011

Re: jhenmal post# 278

Saturday, 10/20/2018 1:33:03 PM

Saturday, October 20, 2018 1:33:03 PM

Post# of 852
Good to see RGBP/Zander/ETNI now engaged in a preclinical study for IBD to further confirm efficacy, safety, in the drug development process. Each phase of drug development thus far has been successful and beyond expectation so would expect that to continue in the preclinical. This will branch to Regen and Zander. This will start to get very interesting with positive results, and moving to clinical studies. IMO, GL.